November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a technical iteration of MitraClip, was found to be safe and effective for edge-...
Heart Valve Technology
This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve replacement (TMVR), transcatheter and surgical valve repairs, ad surgical replacement valves.
-
-
Here is a list of the key late-breaking clinical study presentations at the 2019 American Heart Association (AHA) annual meeting, Nov. 16-18, 2019, in Philadelphia.
-
November 6, 2019 — Cleveland Clinic announced the Top 10 Medical Innovations for 2020 at a multimedia presentation last month that capped off...
-
November 6, 2019 — Edwards Lifesciences announced it received European CE mark to expand use of the Edwards Sapien 3 transcatheter aortic valve replacement (TAVR) device for the treatment of...
A sample of the transcatheter mitral valve replacement (TMVR) devices in development or clinical trials.
Feature | Heart Valve Technology | November 27, 2019 | Saipriya Iyer
The overwhelming success story for transcatheter aortic valve replacement (TAVR) moving from a science project to...
A key slide from the TRILUMINATE study one-year results showing the improvement in tricuspid regurgitation from basement with treatment using the transcatheter TriClip device.
News | Heart Valve Technology | November 26, 2019 | Dave Fornell, Editor
November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a...
Feature | AHA | November 19, 2019 | Dave Fornell, Editor
November 19, 2019 — Here is a list of the key late-breaking clinical study presentations and links to the results at...
One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.
News | November 06, 2019
November 6, 2019 — Cleveland Clinic announced the Top 10...
Feature | November 06, 2019
November 6, 2019 — Edwards Lifesciences announced it received European CE mark to expand use of the Edwards Sapien 3...
The first all-women panel discussion on structrual heart cases was held at TCT 2019. Rebecca Hahn, M.D., foreground, was the co-organizer of the Women in Structural Heart (WISH) evening session.
Blog | Structural Heart | November 04, 2019
My observation over the 13 years covering cardiology is that it is a heavily male-dominated field. This is more...
EchoPixel showed technology at TCT 2019 that creates live holograms in the cath lab from 3-D TEE imaging. It projects the holograms on a special display screen that does not require the user to wear 3-D glasses. The interventional cardiologist can use hand movements and a foot switch to move the image around without breaking the sterile field. It offers a new way to visualize catheters, device positioning and deployment in structural heart procedures. (Photos by Dave Fornell)
Feature | TCT | November 04, 2019 | Dave Fornell, Editor
The latest in interventional cardiology clinical data and new device technologies were highlighted at the annual...
Former National Football League (NFL) player Ed White (left) needed a new aortic heart valve, but decided to wait several months for the FDA to approve TAVR for low-risk patients so he would not have to undergo open heart surgery. Democratic presidential candidate Sen. Bernie Sanders received two stents after he was hospitalized with chest pain was hospitalized with chest pain on Oct. 1 in Las Vegas. The event brought PCI to the forefront of national news in October.
Feature | November 01, 2019 | Dave Fornell, Editor
November 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (...
Retired National Football League (NFL) star Ed White, the former Chargers guard and four-time Pro Bowler, waited until the FDA approved TAVR for low-risk patients like himself to avoid open-heart surgery.
Feature | Heart Valve Technology | October 29, 2019
October 29, 2019 — When Scripps cardiologists discovered early in 2019 that retired National Football League (NFL)...
Videos | Vascular Closure Devices | October 17, 2019
Videos | Heart Valve Technology | October 09, 2019
Videos | TCT | October 04, 2019
A Sapien 3 TAVR valve in position as seen under GE Assist guidance on angiography.
News | Heart Valve Technology | October 04, 2019
October 4, 2019 – A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-...
The COAPT Economic Analysis sub-study found it is cost effective to treat heart failure patients who have severe secondary mitral regurgitation with MitraClip to reduce their MR symptoms.
News | Heart Failure | October 04, 2019
October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve...
